Literature DB >> 9797211

Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

A Saleh Mghir1, A C Crémieux, R Bleton, F Ismael, M Manteau, S Dautrey, L Massias, L Garry, N Sales, B Mazière, C Carbon.   

Abstract

Prosthesis infections are difficult to cure. Infection with methicillin-resistant staphylococci is becoming more common in patients with orthopedic implants. Using a recently developed model of methicillin-resistant Staphylococcus aureus (MRSA) infection of a knee prosthesis, we compared the efficacies of teicoplanin and vancomycin. [14C]teicoplanin diffusion in this model was also studied by autoradiography. A partial knee replacement was performed with a silicone implant fitting into the intramedullary canal of the tibia, and 10(7) CFU of MRSA was injected into the knee. Treatment with teicoplanin or vancomycin (20 or 60 mg/kg of body weight, respectively, given intramuscularly twice daily) was started 7 days after inoculation and was continued for 7 days. The teicoplanin and vancomycin MICs for MRSA were 1 microg/ml. Mean peak and trough levels in serum were 39.1 and 23.5 microg/ml, respectively, for teicoplanin and 34.4 and 18.5 microg/ml, respectively, for vancomycin. Fifteen days after the end of therapy, the animals were killed and their tibias were removed, pulverized, and quantitatively cultured. Teicoplanin and vancomycin significantly reduced (P < 0. 05) the bacterial density (2.7 +/- 1.3 and 3.3 +/- 1.6 log10 CFU/g of bone, respectively) compared to those for the controls (5.04 +/- 1.4 log10 CFU/g of bone). The bacterial covents of teicoplanin- and vancomycin-treated rabbits were comparable. The [14C]teicoplanin autoradiographic diffusion patterns in rabbits with prostheses, two of which were uninfected and two of which were infected, were studied 15 days after inoculation. Sixty minutes after the end of an infusion of 250 microCi of [14C]teicoplanin, autoradiography showed that in the infected animals, the highest levels of radioactivity were located around the prosthesis and in the periosteum, bone marrow, and trabecular bone. Radioactivity was less intense in epiphyseal disk cartilage, femoral cartilage, articular ligaments, and muscles and was weak in compact bone. A similar distribution pattern was seen in uninfected rabbits. Thus, teicoplanin may represent an effective alternative therapy for the treatment of these infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797211      PMCID: PMC105951     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  High-performance liquid chromatography of antibiotics.

Authors:  F Jehl; C Gallion; H Monteil
Journal:  J Chromatogr       Date:  1990-10-12

2.  Oral antimicrobial therapy for osteomyelitis.

Authors:  L O Gentry
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

3.  Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations.

Authors:  A F Widmer; A Gaechter; P E Ochsner; W Zimmerli
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

4.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.

Authors:  C M Brandt; W W Sistrunk; M C Duffy; A D Hanssen; J M Steckelberg; D M Ilstrup; D R Osmon
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

5.  Selection and training of patients for outpatient intravenous antibiotic therapy.

Authors:  R B Brown
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

6.  Teicoplanin--home therapy for prosthetic joint infections.

Authors:  P G Davey; D R Rowley; G A Phillips
Journal:  Eur J Surg Suppl       Date:  1992

7.  Experimental osteomyelitis: description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis.

Authors:  R H Fitzgerald
Journal:  J Bone Joint Surg Am       Date:  1983-03       Impact factor: 5.284

8.  Evaluation of new anti-infective drugs for the treatment of infections of prosthetic hip joints. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  C Norden; J D Nelson; J T Mader; G B Calandra
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 9.  Lessons learned from animal models of osteomyelitis.

Authors:  C W Norden
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

10.  High teicoplanin uptake by human neutrophils.

Authors:  E G Maderazo; S P Breaux; C L Woronick; R Quintiliani; C H Nightingale
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

View more
  8 in total

1.  Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbits.

Authors:  Eric G Solon; James A Dowell; Jonghui Lee; S Peter King; Bharat D Damle
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

2.  Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis.

Authors:  Lars Helbig; Hans Georg Simank; Helga Lorenz; Cornelia Putz; Christoph Wölfl; Arnold J Suda; Arash Moghaddam; Gerhard Schmidmaier; Thorsten Guehring
Journal:  Int Orthop       Date:  2013-10-30       Impact factor: 3.075

3.  Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.

Authors:  Azzam Saleh-Mghir; Oana Dumitrescu; Aurélien Dinh; Yassine Boutrad; Laurent Massias; Emilie Martin; François Vandenesch; Jérôme Etienne; Gérard Lina; Anne Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

4.  Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.

Authors:  Azzam Saleh-Mghir; Claudette Muller-Serieys; Aurélien Dinh; Laurent Massias; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.

Authors:  Azzam Saleh-Mghir; Nourdine Ameur; Claudette Muller-Serieys; Farid Ismael; Françoise Lemaitre; Laurent Massias; Céline Feger; Rémy Bléton; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

6.  Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.

Authors:  Farid Ismael; Rémy Bléton; Azzam Saleh-Mghir; Sophie Dautrey; Laurent Massias; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Oritavancin Pharmacokinetics and Bone Penetration in Rabbits.

Authors:  Dario Lehoux; Valerie Ostiguy; Cordelia Cadieux; Mireille Malouin; Odette Belanger; Adel Rafai Far; Thomas R Parr
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

8.  Efficacy of Nanoencapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus Bone and Joint Infection Model.

Authors:  Cedric Jacqueline; Jocelyne Caillon; Olivier Meyer; Eric Dailly; Carl Simonsson; Vincent Lenaerts; Karim Asehnoune; Amokrane Reghal; Gilles Potel
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.